Secondary Logo

Journal Logo

Erratum

Contrast Media Research 2017 Durango, Colorado USA, October 22–25, 2017 Convener: Michael F. Tweedle, PhD: Erratum

Author Information
doi: 10.1097/RLI.0000000000000445
  • Free

In “Contrast Media Research 2017 Durango, Colorado USA, October 22–25, 2017 Convener: Michael F. Tweedle, PhD”1, which were published in Volume 52, Issue 12 of Investigative Radiology, are herein corrected. The corrections are only the addition of the institution(s) from which the abstracts were derived.

1

New concepts and new data in allergic hypersensitivity reactions to contrast media: practical implications and comparison between European and American guidelines

O.Clément

Paris Cardiovascular Research Center, INSERM U970, Université Paris Descartes, Sorbonne Paris Cité, and department of Radiology, Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges Pompidou

2

Contrast Media Nephrotoxicity in CT? What have we learned in the past 5 years?

Richard Solomon

Robert Larner College of Medicine, University of Vermont Medical Center, Nephrology Division

3

Hydration to Prevent Kidney Injury in the Cardiac Lab: is it what goes in or what comes out that is important?

Richard Solomon

Robert Larner College of Medicine, University of Vermont Medical Center, Nephrology Division

4

Analytical interference by contrast agents in biochemical assays

Sigrid Otnes, Niels Fogh-Andersen, Janne Rømsing, Henrik S. Thomsen

Faculty of Health and Medical Sciences, University of Copenhagen, DK-2100 Copenhagen Ø, Denmark; Departments of Clinical Biochemistry and Radiology, Copenhagen University Hospital Herlev-Gentofte, DK-2730 Herlev, Denmark

5

Tantalum nanoparticles as a potential X-ray/CT contrast agent for the larger body habitus

Paul F. FitzGerald1, Peter J. Bonitatibus, Jr.1, Matthew D. Butts1, Andrew S. Torres2, Robert E. Colborn1, Jack W. Lambert3, Yuxin Sun3, Jeannette C. Roberts1, Michael E. Marino1, Peter M. Edic1, Benjamin M. Yeh3

1GE Global Research, Niskayuna, NY, USA; 2Regeneron Pharmaceuticals, Rensselaer, NY, USA; 3UCSF, San Francisco, CA, USA

6

Pre-amplified nanoparticle contrast agents for multi-color computed tomography

Shatadru Chakravarty, Stacey M. Forton, Erik M. Shapiro

Department of Radiology, Michigan State University, East Lansing, MI 48824

7

Silver-based nanoparticles as contrast agents for dual-energy mammography and other modalities

Pratap C. Naha, Jessica C. Hsu, Kristen C. Lau, Renee Hastings, Maryam Hajfathalian, Shaameen Mian, Lahari Uppuluri, Peter Chhour, Walter R. Witschey, Elizabeth McDonald, Andrew D. Maidment, David P. Cormode

Radiology Department, University of Pennsylvania, Philadelphia, USA

8

Piezoelectric Bioprinting of Ethiodized Oil-impregnated Microcapsules For Embolic and Cell Therapies

Yingli Fu1, Tsang Chung Charles Hu2, Hai-Quan Mao2, Peter C Searson2, and Dara L Kraitchman1

1Department of Radiology and Radiological Science and 2Department of Materials Science and Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

9

Comparison of Doxorubicin and Epirubicin Deliveries Following Chemoembolization in a Rat Liver Tumor Model.

W González, S Rizzitelli, C Robic, S Catoen, P Robert, JM Idée, C Corot

Guerbet, Research and Innovation, Aulnay-sous-Bois, France

10

Exploring a new role for the old-fashioned iodinated contrast media as chemical-exchange spin-lock (CESL) agents

DL Longo1, E Cavallari2, L Consolino2, A Anemone2, M Bracesco2, S Aime2

1 Istituto di Biostrutture e Bioimmagini (IBB), Consiglio Nazionale delle Ricerche (CNR), Torino, ITALY

2 Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, Università degli Studi di Torino, Torino, ITALY

11

Potential contrast agent usage at multi-energy CT

BM Yeh, Y Sun, R Kumar, Z Li, M Wong, JW Lambert, ZJ Wang University of California – San Francisco, San Francisco, CA, USA.

12

Development of a Kidney Safe Iodinated Contrast agent: Preclinical Studies

Rowe ES, Rowe VD, Biswas S, Mosher G, Insisienmay L, Ozias MK, Gralinski MR, Hunter J, Barnett JS

Verrow Pharmaceuticals, Inc, Rowe ES, Mosher G., Lenexa, KS; Rowe Neurology Institute, Rowe VD, Biswas S, Insisienmay L, Ozias, MK, Hunter J, Barnett JS, Lenexa, KS; CorDynamics, Inc. Gralinski MR, Chicago, IL.

13

Clinical 19F MRI of a Labeled Cell Product: How to Navigate the FDA and Obtain an IND

Jeff W.M. Bulte1, L. Gapasin1, Laura C. Rose1, Dara L. Kraitchman1, Guan Wang1, Li Pan2,

Ruud B. van Heeswijk3, Brooke M. Helfer4, Charles F. O’Hanlon4, Ricardo L. Rodriguez5.

1Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; 2Siemens Healthcare, Baltimore, MD 21287; 3Department of Radiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland; 4Celsense Inc., Pittsburgh, PA 15222, USA; 5CosmeticSurg LLC, Lutherville, MD 21093, US

14

19 F/1H MR Characterization of Angiogenesis and Response to Dust Mite Triggered Asthma in the Brown Norway Rat

GM Lanza1,2, AH Schmieder1, A Moldobaeva2, G Cui1, H Zhang1, X Yang1, Q Zhong2, L Eldridge2, JS Allen1, T Williams1, MJ Scott1, EM Wagner2

1 Department of Medicine, Washington University School of Medicine, St. Louis, MO

2 Department of Medicine, Johns Hopkins University, Baltimore, MD

15

Design of CEST MRI-visible pH Sensors for detecting kidney injury

Kowsalya Pavuluri, Nikita Oskolkov1,2, Xing Yang1, Martin Pomper1, Michael T. McMahon1,2

1Department of Radiology,Johns Hopkins University School of Medicine;2F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, United States;

16

Detecting metabolic pathways in vivo using parahydrogen hyperpolarized [1-13C]pyruvate.

F Reineri, E Cavallari, C Carrera, S Aime

Università degli Studi di Torino, Dept. Molecular Biotechnology and Health Sciences, Torino, Italy.

17

A Janus Chelator Enables Biochemically Responsive MRI Contrast with Exceptional Dynamic Range

Eric M. Gale, Chloe M. Jones, Ian Ramsay, Christian T. Farrar, Peter Caravan

The Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 149 Thirteenth Street, Suite 2301, Charlestown, Massachusetts 02129

18

Molecular MR imaging of fibrogenesis

Peter Caravan

Institute for Innovation in Imaging, Department of Radiology, Massachusetts General

Hospital, Harvard Medical School, Boston, USA

19

Characterization and Redox Response of EuII-Based Contrast Agents for Magnetic Resonance Imaging

LA Basal, CU Lenora, MJ Allen

Department of Chemistry, Wayne State University, Detroit, MI 48202, USA

20

Imaging Zn(II) release from secretory tissues by MRI: A potentially powerful method for early detection of prostate cancer

Dean Sherry, V. Clavijo-Jordan, A. Martins, C. Preihs, S. Chirayil, and S.T Lo

Department of Chemistry, University of Texas at Dallas, Richardson, TX 75083

Advanced Imaging Research Center & Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX 75390

21

PET/MR imaging of oxidation-specific epitopes in atherosclerosis

Max L. Senders1,2; Xuchu Que3; Yong Seok Cho4,5; Calvin Yeang5; Hannah Groenen1; François Fay1; Claudia Calcagno1; Simone Green5; Phuong Miu5; Mark E. Lobatto6; Thomas Reiner7,8; Zahi A. Fayad1; Joseph L. Witztum3; Willem J.M. Mulder1,2; Sotirios Tsimikas5; Carlos Pérez-Medina1

1Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

2Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands

3Division of Endocrinology and Metabolism, Department of Medicine, University of California, La Jolla, San Diego, CA, USA.

4Seoul National University College of Medicine, Seoul National University Bundang Hospital

5Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, Department of Medicine, University of California, La Jolla, San Diego, CA, USA.

6Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands

7Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

8Department of Radiology, Weill Cornell Medical College, New York, NY, USA

22

Nanobody-facilitated multiparametric PET/MRI phenotyping of experimental atherosclerosis

Max L. Senders1,2, Sophie Hernot3, Giuseppe Carlucci4, Jan van de Voort1, Francois Fay1,5, Claudia Calcagno1, Amr Alaarg1, Yiming Zhao1, Jun Tang6, Alexis Broisat7, Geert Raes8, Thomas Reiner6,9 Zahi A. Fayad1, Nick Devoogdt3, Willem J. Mulder1,2, Carlos Pérez-Medina1

1 Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

2 Department of Medical Biochemistry, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands

3 In vivo Cellular and Molecular Imaging laboratory, Vrije Universiteit Brussel, 1090, Brussels, Belgium

4 Bernard and Irene Schwarz Center for Biomedical Imaging, New York University, New York, NY 10016, USA

5 Department of Chemistry, York College of The City University of New York, New York, NY 11451, USA

6 Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA

7 Bioclinic Radiopharmaceutics Laboratory, INSERM UMR S 1039, Grenoble, 38700 La Tronche, France

8 Research Group of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium; Laboratory of Myeloid Cell Immunology, VIB Inflammation Research Center, Ghent, Belgium.

9 Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA

23

PET Molecular Imaging of EDB Fibronectin for Characterization of Prostate Cancer Aggressiveness

Z Han1, P Qiao1, S Roelle1, H Cheng1, X Wu1, O Sergeeva2, Z Lee2 and Z Lu1

1Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA

2Department of Radiology, Case Western Reserve University, Cleveland, OH 44106, USA

24

New Tumor-Selective APC Metal Chelates for PET Imaging and Targeted Radiotherapy

R Hernandez, J Grudzinski, R Zhang, J Jeffery, A Pinchuk, J Weichert

Department of Radiology, University of Wisconsin, Madison, Wisconsin.

69

Gadolinium deposition in a retrospective pig study with high similarity to

clinical conditions

J Boyken,1 T Frenzel,2 J Lohrke, G Jost,2 and H Pietsch2

1 Institute of Physiology, Charité University Medicine, Berlin, Germany, 2Bayer AG, Berlin, Germany

25

Immediate Allergic Reactions to Gadolinium Based Contrast Agents: a Systematic Review and Meta-Analysis

Ashkan Heshmatzadeh Behzadi, Zerwa Farooq, Yize Zhao, Martin R. Prince Department of Radiology, Weill Cornell Medical Center; and Department of Radiology, Columbia College of Physicians and Surgeons, New York, NY.

26

The Effect of Gadolinium Based Contrast Agents (Gbcas) For Ion Balance In Tissues: A Preliminary Study

Khongorzul Erdene,1, Takahito Nakajima 1, Satomi Kameo 2, Adhipatria Kartamihardja 1, Hiroshi Koyama 2, Yoshito Tsushima 1,3

1) Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Japan.

2) Department of Public health, Gunma University Graduate School of Medicine, Japan.

3) Research Program for Diagnostic and Molecular Imaging, Division of Integrated Oncology Research, Gunma University Initiative for Advanced Research (GIAR), Gunma Japan.

27

Accumulation of gadolinium in human cerebrospinal fluid following gadobutrol-enhanced MR imaging.

A. Nehra, R. McDonald, A. Bluhm, T. Gunderson, D. Murray, P. Jannetto, D. Kallmes, L. Eckel, J. McDonald

Mayo Clinic, Rochester, MN

28

Assessment of the Neurologic Effects of Intracranial Gadolinium Deposition

Using a Large Population Based Cohort

R McDonald, 1 J McDonald, 1 L Eckel, 1 D Kallmes, 1,2 R Carter,3 T Therneau,3 C Jack, 1,4 R Petersen4

Departments of 1Radiology, 2Neurosurgery, 3Biostatistics, and 4Neurology, Mayo Clinic, Rochester, MN, USA

29

Dentate Nucleus Signal Intensity Decrease on T1-Weighted MR Images after Switching from Linear to Macrocyclic GBCA

Ashkan Heshmatzadeh Behzadi, Zerwa Farooq, Yize Zhao, Martin R. Prince

Department of Radiology, Weill Cornell Medical Center; and Department of Radiology, Columbia College of Physicians and Surgeons, New York, NY.

30

Gadolinium retention following repeated dosing: do all macrocyclic agents behave the same way?

Fabio Tedoldi1, Simona Bussi1, Alessandra Coppo1, Catherine Botteron2, Valérie Fraimbault2, Antonello Fanizzi1, Elisa De Laurentiis1, Sonia Colombo Serra1, Federico Maisano1

1 Centro Ricerche Bracco, Bracco Imaging Spa, Via Ribes 5, I-10010 Colleretto Giacosa (TO), Italy

2 Geneva Research Center and Manufacturing Site, Bracco Suisse SA, 31, route de la Galaise, CH-1228 Plan-Les-Ouates (CH)

31

Gadolinium-retention effect on brain resting state functional connectivity in patients with inflammatory Bowel disease and repetitive not-confounded i.v. exposure to gadodiamide.

Carlo Cosimo Quattrocchi1, Claudia Piervincenzi2, Vincenzo Cirimele1, Filippo Carducci2

Ed. Note: first author surname omitted. Dose was 0.1 mmol/kg, not 0.01 mmol/kg.

1 Departmental Faculty of Medicine and Surgery, Center for Integrated Research, University Campus Bio-Medico of Rome, Rome, Italy.

2 Department of Physiology and Pharmacology, Neuroimaging Laboratory, Sapienza University, Rome, Italy.

32

Cerebellar Gadolinium Uptake: Non-Clinical Evidence and Mechanistic

Hypotheses

M Rasschaert, J-M Idée, J A Schroeder, K Medjoubi, P Robert, J-L Guerquin-Kern,

S Marco, J Letien, V Vives, E M’Boumba, C Factor, A Emerit, N Fretellier, C Corot, C Brochhausen.

Research & Innovation, Guerbet, Aulnay-sous-Bois, France ; Institut für Pathologie, Uniklinikum Regensburg, Regensburg, Germany ; Synchrotron SOLEIL, Nanoscopium Beamline, Gif-sur-Yvette, France ; INSERM, U1196, Institut Curie, Orsay, France, Université Paris-Saclay; CNRS, UMR 9187, Orsay, France

33

Investigations into the retention of Gd in the brain following repeated doses

of gadolinium based contrast agents in a preclinical model

Marino ME, Smith A, Crowder J, Lowery L, Morton C, Castle J, Cotero V, Hibberd M,

Evans P

GE Heathcare

34

Long-term Study of Residual Gd in Brain after Repeated Injection of Gd

based Contrast Agents in Rats

Thomas Frenzel, Gregor Jost, Jessica Lohrke, and Hubertus Pietsch

Bayer AG, Berlin, Germany

35

Advocating Development of Second Generation High Relaxivity Gadolinium Chelates for Clinical MR

V Runge, J Heverhagen

University Institute of Diagnostic, Interventional and Pediatric Radiology, Inselspital, Bern, Switzerland

36

Translational Imaging in Drug Safety Assessment - TRISTAN: A publicprivate partnership to validate MR imaging methods for their efficient and reliable use in drug safety assessment

Gunnar Schütz, Sabina Ziemian, and Hubertus Pietsch

Bayer AG, Berlin, Germany

37

Super-resolution ultrasound imaging for improved quantification of microvascular networks

D. Ghosh1,2, Robert F Mattrey2, K Hoyt1,2

1 University of Texas at Dallas, Richardson, TX, USA; 2 University of Texas Southwestern Medical Center, Dallas, TX, USA

38

Contrast-enhanced Ultrasound with Time-intensity curves obtained after Sulphur Hexafluoride-filled Microbubble Injection in patients Crohn’s disease: Differentiation of Responders from non-Responders and Differentiation of Inflammatory from Fibrotic Ileal Strictures

Emilio Quaia,1 Antonio Giulio Gennari2

1 Edinburgh Imaging facility, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ

2 Department of Radiology, Cattinara Hospital, University of Trieste, Strada di Fiume 447, 34149, Trieste (Italy)

39

Theoretical and experimental investigation of the nonlinear dynamics of nanobubbles excited at clinically relevant ultrasound frequencies and pressures: the role of lipid shell buckling

Amin Jafari Sojahrood2, Lenitza Nieves1, Christopher Hernandez1, Agata A. Exner1, Michael C. Kolios2

Departments of Radiology1 Case Western Reserve University, Cleveland, Ohio, USA; 2Department of Physics, Ryerson University, Toronto, Canada

40

Toward successful ultrasound molecular imaging of cancer with nanobubble contrast agents

C Hernandez1, L Nieves1, J Lilly1, H Xia1, A Ankher1, X Wang1, G Ramamurthy1, R Advincula2, J Basilion1, MC Kolios3, AA Exner1

Departments of Radiology1 & Macromolecular Science2, Case Western Reserve University, Cleveland, Ohio, USA; 3Department of Physics, Ryerson University, Toronto, Canada

41

Targeted Ultrasound Contrast Agent for Vulnerable Plaque

E Unger, F Mocetti, C Weinkauf, K Hadinger, B Davidson, T Belcik, T Matsunaga,

E Marinelli, and J Lindner

Department of Radiology, University of Arizona, Tucson, AZ, USA; Oregon Health and Science University, Portland, OR, USA; Department of Surgery, University of Arizona, Tucson, AZ, USA; Department of Biomedical Engineering, University of Arizona, Tucson, AZ, USA; Oregon Health and Science University, Portland, OR, USA; University of Virginia School of Medicine, Charlottesville, VA, USA; Department of Medical Imaging, University of Arizona, Tucson, AZ USA; NuvOx Pharma, Tucson, AZ, USA; Department of Medicine, Oregon Health & Science University, Portland, OR, USA

42

Direct Formulation of Superheated Nanodroplets with Improved Properties

C de Gracia Lux1, J Lux1, A M Vezeridis2, A M Armstrong1, S Sirsi3,1, K Hoyt3,1, R F Mattrey1

1Radiology, UT Southwestern Medical Center, Dallas, TX, 2Radiology, UC San Diego, La Jolla, CA, 3Bioengineering, University of Texas at Dallas, Richardson, TX.

43

Ultrasound molecular imaging of diet-induced obesity inflammation via VCAM-1-targeted microbubbles

S. Unnikrishan, Z. Du, M. Zhang, Z. Yan, A.L. Klibanov

Cardiovascular Division, Department of Medicine, Department of Biomedical Engineering, Cardiovascular Research Center, School of Medicine, University of Virginia, Charlottesville VA 22908

44

Thrombin-Activatable Ultrasound Contrast Agent for the Detection of Acute Thrombosis

J Lux1, A M Vezeridis2, K Hoyt3,1, S R Adams4, A M Armstrong1, S R Sirsi3,1, R F Mattrey1

1Radiology, UT Southwestern Medical Center, Dallas, TX, 2Radiology, UC San Diego, La Jolla, CA, 3Bioengineering, University of Texas at Dallas, Richardson, TX, 4Pharmacology, UC San Diego, La Jolla, CA.

45

Perfluoropropane Microspheres for Ultrasound Imaging of Inflammation: Probe Design and Nonclinical Evaluation

Alice Luong1, Dan Smith1, Chia-Hung Tai1 Bruno Cotter3, Colin Luo3, Monet Strachen3, Anthony DeMaria3, Klaus Ley2,4, Joshua J. Rychak1, 2

1.Targeson, Inc; 2.University of California San Diego, Department of Bioengineering; 3. University of California San Diego, Division of Cardiovascular Medicine; 4. La Jolla Institute for Allergy and Inflammation, Division of Inflammation Biology

46

Comparison of a Gadolinium-Based Nanoparticle with Gd-DOTA for MR Lymphography in a Rat Lymphedema Model at 9.4 T.

P Fries1, F. Frueh2, F Lux3, O Tillement3, A Buecker1, G Schneider 1 A Müller1

1Clinic of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg, Germany

2Institute for Clinical and Experimental Surgery, Saarland University, Homburg/Saar, Germany

3Laboratoire de Physico-Chimie des Matériaux Luminescents, Université Claude Bernard, Lyon, France

47

Theranostic gadolinium based nanoparticles (AGuIX) for the treatment of multiple brain metastases: First in Man

Camille Verry1,2, François Lux3,4, Sandrine Dufort4, Olivier Tillement3,4, Géraldine Le Duc4, Jacques Balosso1,2

1 Department of Radiotherapy, Grenoble Alpes University Hospital, BP217, F38043 Grenoble, Cedex 9, France

2 Equipe d'accueil Rayonnement Synchrotron et Recherche Médicale, Grenoble Alpes University, European Synchrotron Radiation Facility - ID17, Grenoble 38043

3 Institute Light & Mater, UMR5306, Lyon1 University, F69622 Villeurbanne, France

4 NH TherAguix, L’Atrium, 43 Boulevard du 11 Novembre 1918, F69100 Villeurbanne, France

48

New Tumor-Selective APC Metal Chelates for PET Imaging and Targeted Radiotherapy

R Hernandez, J Grudzinski, R Zhang, J Jeffery, A Pinchuk, J Weichert

Department of Radiology, University of Wisconsin, Madison, Wisconsin.

49

In vivo Cerenkov imaging of cellular energetics in breast cancer cells with different metastatic potential

Alejandro D. Arroyo, Brianna Moon, Alexander Kachur, Anatoliy V. Popov, E. James Delikatny

Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

50

Near infrared photoimmunotherapy, a highly selective theranostics, rapidly

elicits host tumor immunity specific to cancer cells

Hisataka Kobayashi.

Molecular Imaging Program, NCI/NIH, Bethesda, MD, USA

51

CuS nanoparticles as a platform for photoacoustic tomographic imaging of tumor vasculature

C Li, M Zhou, Shixiang Shi, Q Huang, L Cui, D Chow

Department of Cancer Systems Imaging, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA; College of Pharmacy, University of Houston, Texas, USA

52

Fluorescent Hyaluronic Acid Nanoparticles Enhance Pancreatic Cancer in Mice for Surgical Navigation

Bowen Qi1, Ayrianne J. Crawford2, Nicholas E. Wojtynek2, Michael A. Hollingsworth3,4, and Aaron M. Mohs1,3,4

1Department of Pharmaceutical Sciences, 2Cancer Research Graduate Program, 3Department of Biochemistry and Molecular Biology, and the 4Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198

53

A Theranostic Contrast Agent for Surgical Removal of Prostate Cancer

Xinning Wang, Joey Mangadlao, Gopolakrishnan Ramamurthy, Ethan Walker, Brian Tsui, Aditi Shirke, Ziying Wang, James P. Basilion

Case Western Reserve University, Cleveland, OH, USA

54

Structure Activity Relationship of Head and Neck Squamous Cell Cancer Targeted Peptides

S Kothandaraman, H Ding, L Gong, CL Wright, MF Tweedle

Wright Center for Innovation in Biomedical Imaging, Department of Radiology, The Ohio State University, Columbus, Ohio 43210.

55

Phospholipase activatable contrast agents for fluorescence guided surgery of breast cancer

M.C. Chiorazzo, A.V. Popov, and E.J. Delikatny

Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA

56

Opening the Proteome to MR Imaging Analysis: Are we there yet?

Thomas J. Meade

Biomedical Engineering, Radiology, Northwestern University

57

Peptide targeted MRI contrast agents for cancer detection and risk-stratification

Zheng Han, Sarah Roelle, Zheng-Rong Lu

Case Center for Biomolecular Engineering, Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA

58

Noninvasive PrecisionMolecularMRImaging (pMRI) of Cancer Molecular Signatures. Collagen-Targeted MRI Contrast Agent: Early Stage Detection of Liver Fibrosis and Tumor Growth Pattern in Liver Metastasis

Mani Salarian, Jingjuan Qiao, Shenghui Xue, Shanshan Tan, Yinwei Zhang, Khan Hekmatyar, Hua Yang, Hans E. Grossniklaus, Zhi-ren Liu, Jenny J. Yang

59

Transfection Free Method of Stem Cell Labeling with Ferumoxytol

H. Nejadnik, 1 S. Taghavigarmestani, 1 K. Li, 1 P. Yang, 2 M. Mahmoudi, 2 H.Daldrup-Link, 1

1 Department of Radiology and Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA. 2 Division of Cardiovascular Medicine, Stanford University, Stanford, CA

60

Measuring Liver Transporter Reduction in Diabetes By Quantitative Dynamic Contrast-Enhanced MRI

Dorela D. Shuboni-Mulligan1, Faryal F. Mir1, Christiane L. Mallett1, Maciej Parys2, Barbara Blanco-Fernandez1, Erik M. Shapiro1

1Department of Radiology, Michigan State University, East Lansing, MI 48824

2Department of Comparative Medicine and Integrative Biology Program, Michigan State University, East Lansing, MI 48824

61

High kinetic inertness of a bis-hydrated GdIII-complex formed with the cyclohexyl fused AAZTA-like ligand

Zsolt Baranyai,1,2 Adrienn Vágner,2 Lorenzo Tei,3 Imre Tóth,2 Silvio Aime,4 Alessando Maiocchi 1

1 Centro Ricerche Bracco, Bracco Imaging Spa, Via Ribes 5, 10010 Colleretto Giacosa (TO), Italy

2 Department of Inorganic and Analytical Chemistry, University of Debrecen, H-4010, Debrecen, Egyetem tér 1, Hungary

3 Dipartimento di Scienze ed Innovazione Tecnologica, Università del Piemonte Orientale "Amedeo Avogadro", Viale T. Michel 11, 15121 Alessandria, Italiy

4 Dipartimento di Biotecnologie Molecolari e Scienze della Salute, Centro di Imaging

Molecolare e Preclinico, Universita` degli Studi di Torino, Via Nizza 52, Torino,

10126, Italy

62

Mn2+ complexes of some 1,4-disubstituted-1,4,7,10-tetraacyclododecanes for MRI: thermodynamic, kinetic and relaxometric studies

Gyula Tircsó,1 Zoltán Garda,1 Ferenc. K. Kálmán,1 Szilvia Lóczi,1 Kristóf Póta,1 Viktória Nagy,1 Tamás Fodor,1 Do N. Quyen,2 Zoltán Kovács 3, Éva Tóth,4 and Imre Tóth1

1 Department of Inorganic and Analytical Chemistry, University of Debrecen, H-4010, Debrecen, Egyetem tér 1, Hungary

2 Department of Radiology, 3 Advanced Imaging Research Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA

4 Centre de Biophysique Moléculaire, CNRS, Rue Charles-Sadron, 45071 Orleans Cedex 2, France

63

Imaging Tumor Associated Macrophages In Bone Sarcomas

Heike E. Daldrup-Link 1,2, Maryam Aghighi1, Anne Muehe1, Florette Kim Hazard3, Neyssa Marina1

1Department of Radiology, Molecular Imaging Program, Stanford University

2Department of Pediatrics (Hematology/Oncology), Stanford University

3Department of Pathology, Stanford University

64

Polymersomes as ultrasensitive MRI probes

A Hannecart1, D. Stanicki1, L. Vander Elst1, 2, R. N. Muller1, 2, S. Laurent1, 2

1NMR and Molecular Imaging Laboratory, General, Organic and Biomedical Chemistry Department, University of Mons, B-7000 Mons, Belgium 2Center for Microscopy and Molecular Imaging, B-6041 Charleroi, Belgium

65

Small-sized iron oxide nanoparticles as potential theranostic agents for MRI

and proton therapy

T. Vangijzegem,1 D. Stanicki,1 S. Boutry,2 L. Vander Elst,1,2 R.N. Muller,1,2 and S. Laurent1,2

1NMR and Molecular Imaging Laboratory, General, Organic and Biomedical Chemistry Department, University of Mons, B-7000 Mons, Belgium 2Center for Microscopy and Molecular Imaging, B-6041 Charleroi, Belgium

66

The superparamagnetic iron oxide nanoparticles as cellular imaging tracking agent for detecting the migration and accumulation of macrophages

Wen-Yuan Hsieh1, Chih-Lung G. Chen1, Hao-Chih Tai2, Jassy Wang1*

1: Megaprobio Inc. Taipei, Taiwan

67

Reintroducing ferumoxtran-10 to non-invasively diagnose small metastatic lymph nodes of prostate cancer

TWJ Scheenen, AS Fortuin, R Brüggeman, J van der Linden, I Panfilov, B Israël, JO Barentsz

Department of Radiology and Nuclear Medicine, Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands

68

Contrast-enhanced-MRI navigated theragnostic research in rats with tumors in pancreatic head and liver

Yicheng Ni1, Ting Yin1, Yewei Liu1,2, Yuanbo Feng1, Jie Yu1, Raymond Oyen1

1Theragnostic Laboratory, Department of Imaging & Pathology, Biomedical Sciences Group, Department of Radiology, University Hospitals, KU Leuven, Herestraat 49, 3000 Leuven, Belgium; 2Department of Nuclear Medicine, School of Medicine, Shanghai Jiaotong University, China

REFERENCE

1. Tweedle M. Contrast Media Research 2017 Durango, Colorado USA, October 22–25, 2017 Convener: Michael F. Tweedle, PhD. Invest Radiol. 2017;52(12):758–778.
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.